IREN Crash Triggers Bullish Buy, but SEC Filings Show Slippage

What happened

IREN shares fell roughly 60% from September highs as Microsoft-related commissioning delays pushed the company's $4 billion ARR target into early 2027, despite a 22% sequential increase in backlog to $20.3 billion. A Seeking Alpha contributor responded by tripling his position and reiterating a Strong Buy, citing AI Cloud revenue of $200 million and sustained customer demand. However, SEC filings show AI Cloud Lease revenue of only $65 million in the September 2026 quarter and FY26 AI Cloud revenue of $128.8 million, suggesting the $200 million figure may be overstated or based on a different metric. Only one Microsoft tranche (Horizon 1) has been accepted, leaving operating ARR near $1 billion versus $4 billion contracted for 2026 capacity. While demand remains strong, the key risk is not customer appetite but IREN's ability to convert backlog into accepted, billable capacity before financing constraints tighten.

Implication

The Seeking Alpha article adds no new verifiable facts; its $200 million AI Cloud revenue claim conflicts with the latest 10-Q showing $65 million in AI Cloud Lease revenue, raising questions about data quality. Backlog growth to $20.3 billion is encouraging, but backlog only matters if it converts to accepted capacity, and the company has already slipped delivery of certain contracted capacity from December 2026 into the following quarter. The remaining $6 billion FY27 capex funding gap remains unresolved, and customer prepayments cover only 45–55% of GPU capex, leaving equity dilution risk if financing markets tighten. Key checkpoints are unchanged: Horizon 2 acceptance by January 31, 2027, and operating ARR progress toward $4 billion over the next two quarters. Until those milestones are met, the stock's risk-reward remains unattractive at current levels, and the WAIT rating stands.

Thesis delta

The news article does not alter the WAIT rating or the key risks. The author's tripling position is a personal decision, not evidence of improved fundamentals, and the $200 million AI revenue figure is inconsistent with SEC filings. Backlog growth is positive but offset by continued acceptance delays and funding uncertainty, so the investment thesis remains unchanged.